These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 11746775

  • 21. IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation.
    Cai Q, Banerjee S, Cervini A, Lu J, Hislop AD, Dzeng R, Robertson ES.
    PLoS Pathog; 2013 Oct; 9(10):e1003751. PubMed ID: 24204280
    [Abstract] [Full Text] [Related]

  • 22. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM, Nguyen VT, Ping Tang LL, Benveniste EN.
    J Immunol; 2001 Feb 15; 166(4):2260-9. PubMed ID: 11160280
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP, Tomasi TB.
    Mol Reprod Dev; 1998 Sep 15; 51(1):1-12. PubMed ID: 9712312
    [Abstract] [Full Text] [Related]

  • 25. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R, Choi JC, Petroff MG, Piskurich JF, Murphy SP.
    Biol Reprod; 2003 Sep 15; 69(3):915-24. PubMed ID: 12748124
    [Abstract] [Full Text] [Related]

  • 26. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME, Lu Y, Jacim M, Ussery GD, Steimle V, Mach B, Blanck G.
    Int J Cancer; 1995 Aug 09; 62(4):461-5. PubMed ID: 7635572
    [Abstract] [Full Text] [Related]

  • 27. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA.
    Tang KC, Trzaska KA, Smirnov SV, Kotenko SV, Schwander SK, Ellner JJ, Rameshwar P.
    J Immunol; 2008 Feb 01; 180(3):1826-33. PubMed ID: 18209080
    [Abstract] [Full Text] [Related]

  • 28. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
    van der Stoep N, Quinten E, Alblas G, Plancke A, van Eggermond MC, Holling TM, van den Elsen PJ.
    Mol Immunol; 2007 Mar 01; 44(8):2036-46. PubMed ID: 17067677
    [Abstract] [Full Text] [Related]

  • 29. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H, Gilbert CA, Hudson JA, Bolick SC, Wright KL, Piskurich JF.
    Mol Immunol; 2007 Feb 01; 44(6):1461-70. PubMed ID: 16765445
    [Abstract] [Full Text] [Related]

  • 30. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
    Kämper N, Franken S, Temme S, Koch S, Bieber T, Koch N.
    FASEB J; 2012 Jan 01; 26(1):104-16. PubMed ID: 21940994
    [Abstract] [Full Text] [Related]

  • 31. Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA.
    Pan H, O'Brien TF, Wright G, Yang J, Shin J, Wright KL, Zhong XP.
    J Immunol; 2013 Jul 15; 191(2):699-707. PubMed ID: 23776173
    [Abstract] [Full Text] [Related]

  • 32. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [Abstract] [Full Text] [Related]

  • 33. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
    Tooze RM, Stephenson S, Doody GM.
    J Immunol; 2006 Oct 01; 177(7):4584-93. PubMed ID: 16982896
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
    Rahat MA, Chernichovski I, Lahat N.
    Int Immunol; 2001 Nov 01; 13(11):1423-32. PubMed ID: 11675374
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.